Search
for

    Sort by

    Research 61–90 of 1000+

    1. New small molecules in dermatology: for the autoimmunity, inflammation and beyond Inflammation Research · 2023 · 9 citations
    2. Dermatologic Adverse Events from Cancer Treatments Springer eBooks · 2018 · 2 citations
    3. Dermatologic Side Effects of Systemic Targeted Anticancer Therapy Springer eBooks · 2018
    4. Vandetanib-associated alopecia areata in a patient with metastatic medullary thyroid cancer International Journal of Dermatology · 2014 · 1 citations
    5. Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy Dermatology Review · 2016 · 4 citations
    6. Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases Chemical Immunology · 2012 · 4 citations
    7. Differential activity of 2-methylene-19-nor vitamin D analogs on growth factor gene expression in rhino mouse skin and comparison to all-trans retinoic acid PloS one · 2017 · 2 citations
    8. Adverse Hair Reactions to New Targeted Therapies for Cancer Actas Dermo-Sifiliográficas · 2019 · 1 citations
    9. Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team International Journal of Clinical Oncology · 2026
    10. Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia PLoS ONE · 2013 · 20 citations
    11. Regulation of Semaphorin3A in the process of cutaneous wound healing Cell Death and Differentiation · 2022 · 13 citations
    12. Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor PLoS ONE · 2012 · 32 citations
    13. Exploring the Mechanism of Platycladi Cacumen in Intervening Androgenetic Alopecia Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation 2025
    14. Topical Application of Aprepitant Inhibits Erlotinib-induced Facial Dermatitis/Hair Loss Journal of dermatology and skin science · 2024
    15. Ritlecitinib: First Approval Drugs · 2023 · 84 citations
    16. Cetuximab-Associated Elongation of the Eyelashes American Journal of Clinical Dermatology · 2010 · 30 citations
    17. Dermatologic Reactions to Targeted Therapy Nursing Clinics of North America · 2017 · 15 citations
    18. Cutaneous Side Effects of Chemotherapy and Radiotherapy 2016 · 2 citations
    19. Clinical-Exome Sequencing Unveils the Genetic Landscape of Polycystic Ovarian Syndrome (PCOS) Focusing on Lean and Obese Phenotypes: Implications for Cost-Effective Diagnosis and Personalized Treatment Research Square (Research Square) · 2024
    20. Self-organization process in newborn skin organoid formation inspires strategy to restore hair regeneration of adult cells Proceedings of the National Academy of Sciences of the United States of America · 2017 · 92 citations
    21. Comparative analysis of stemness between dermal papilla cells and human dermalstem/progenitor cells Cellular and Molecular Biology · 2025
    22. TGF-β Family Signaling in Epithelial Differentiation and Epithelial–Mesenchymal Transition Cold Spring Harbor Perspectives in Biology · 2017 · 82 citations
    23. The patient outcomes with EGFR-mutated advanced non-small-cell lung cancer receiving aumolertinib as first-line treatment. Journal of Clinical Oncology · 2024 · 1 citations
    24. EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management Oncology and therapy · 2017 · 29 citations
    25. EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines Anti-Cancer Drugs · 2023 · 7 citations
    26. Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment Clinical and Translational Science · 2025
    27. Epiregulin promotes hair growth via EGFR‐medicated epidermal and ErbB4‐mediated dermal stimulation Cell Proliferation · 2020 · 9 citations
    28. Cutaneous side-effects of EGFR inhibitors and their management. PubMed · 2011 · 38 citations
    29. Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers Annals of Dermatology · 2011 · 3 citations
    30. IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes 2019 · 32 citations